Results 1 to 10 of about 10,897 (217)

Chronic Inflammatory Demyelinating Polyneuropathy [PDF]

Journal of the Neurological Sciences, 2019
Chronic inflammatory demyelinating polyneuropathy (CIDP) is immune-mediated neuropathy defined by clinical progression for more than 2 months, and electrodiagnostic evidence of peripheral nerve demyelination. However, there are several clinical phenotypes, classified into "typical CIDP," and "atypical CIDP" such as "multifocal acquired demyelinating ...
Satoshi, Kuwabara, Sonoko, Misawa
core   +5 more sources

[Chronic inflammatory demyelinating polyneuropathy]. [PDF]

Ugeskrift for laeger, 2020
In this review, we discuss chronic inflammatory demyelinating polyneuropathy (CIDP), which is a disease with proximal and distal weakness and sensory disturbances resulting in impaired daily activity. The diagnosis is based on the clinical presentation and electrophysiology demonstrating demyelination in the peripheral nerves.
Markvardsen, Lars Kjøbsted, Harbo, Thomas, Holbech, Jakob Vormstrup, Tankisi, Hatice, Christiansen, Ingelise, Olsen, Niels Kjær, Jakobsen, Johannes, Sindrup, Søren Hein, Andersen, Henning   +8 more
core   +7 more sources

Depression with chronic inflammatory demyelinating polyneuropathy [PDF]

Indian Journal of Psychological Medicine, 2018
Depression and chronic inflammatory demyelinating polyneuropathy (CIDP) both are chronic illness of different etiopathology and are usually not looked for together while screening a patient. However, both have got a long incubation period as well as have
Arun Marwale, Manaswi Gautam, Gaurav Murambikar, Manik Bhise, Anand Soni   +4 more
doaj   +3 more sources

Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy [PDF]

Blood Cancer Journal
Ciltacabtagene-autoleucel (cilta-cel) is a CAR-T cell therapy highly active in relapsed/refractory multiple myeloma but can induce severe immune-mediated toxicities. We describe two patients who developed chronic inflammatory demyelinating polyneuropathy
M. Korenkov, J. Liebaert, S. Yousefian, S. Schwartz, U. M. Demel, J. Braune, M. C. Odabasi, L. Herzberg, D. Böckle, N. C. Görür, V. v. Landenberg-Roberg, S. Bohl, E. Tregel, S. Hennig, C. Franke, S. Haas, U. Keller, J. Krönke, A. Busse   +18 more
doaj   +2 more sources

Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy [PDF]

Annals of Clinical and Translational Neurology
Objective To evaluate the utility of smartwatch and smartphone‐based activity metrics for assessing disease severity and quality of life in patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
Lars Masanneck, Jan Voth, Noëmi Gmahl, Konstantin Jendretzky, Niklas Huntemann, Noah M. Werner, Linea Schmidt, Menekse Oeztuerk, Paula Quint, Christina B. Schroeter, Hans Peter Hartung, Thomas Skripuletz, Gerd Meyer zu Hörste, Tobias Ruck, Sven G. Meuth, Marc Pawlitzki   +15 more
doaj   +2 more sources

Chronic inflammatory demyelinating polyneuropathy [PDF]

Journal of the Neurological Sciences, 2013
Chronic inflammatory demyelinating polyneuropathy (CIDP) is characterized clinically by a progressive symmetrical weakness evolving over a period of at least 2 months. There is increased CSF protein and conduction block, reduced nerve conduction velocities, increased distal latencies, and/or absent F wave or prolonged F wave latency in two or more ...
Michel, Vanasse, Elsa, Rossignol, Elie, Hadad   +2 more
  +9 more sources

Hymenoptera sting as atypical causative factor for Guillain Barré Syndrome and chronic inflammatory demyelinating polyneuropathy – A case report and insights on pathophysiology [PDF]

Romanian Journal of Neurology, 2023
Introduction. Neurological manifestations secondary to Hymenoptera stings are rare. However, the literature describes cases of severe central and peripheral nervous system damage.
Cristina Gatcan, Thomas Gabriel Schreiner, Violeta Sapira, Cristina Grosu, Bogdan Emilian Ignat   +4 more
doaj   +1 more source

Neurosarcoidosis camouflaging as partial miller: Fisher syndrome

Indian Journal of Rheumatology, 2023
Neurological involvement in sarcoidosis has varied presentations. Peripheral neuropathy is one of them. Symmetrical axonal type sensory-motor polyneuropathy is the most common form; focal and multifocal neuropathy, polyradiculopathy, and vascular ...
B N Shiva Prasad, Subramanian Ramaswamy, Aumir Moin, Srinivas Nalloor   +3 more
doaj   +1 more source

Progressive muscle weakness and amyotrophy during pregnancy as the first manifestation of systemic lupus erythematosus: A case report and review of literature

Science Progress, 2021
Background: Systemic lupus erythematosus is a common autoimmune disease involving multiple systems. Clinical involvement of the central and peripheral nervous systems is not unusual, but peripheral neuropathy in systemic lupus erythematosus with chronic ...
Liu Wang, Dan Wang, Yuyi Ruan, Xionghui Chen, Wei Chen, Zhijian Li, Xin Wang   +6 more
doaj   +1 more source

Ibrutinib-induced chronic demyelinating polyneuropathy in a 65-year-old man with chronic lymphoid leucosis: a clinical case [PDF]

Romanian Journal of Neurology, 2018
Relevance. Most of oncological patients undergo chemotherapy, which has a wide range of various toxic reactions including polyneuropathy. Ibrutinib is a relatively new medicine with a few side effects associated with peripheral polyneuropathy ...
N.A. Suponeva, D.A. Grishina, M.A. Piradov   +2 more
doaj   +1 more source